nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0682	0.463	CbGbCtD
Calcitriol—CYP3A4—Progesterone—uterine cancer	0.0452	0.306	CbGbCtD
Calcitriol—GC—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.032	0.0953	CbGpPWpGaD
Calcitriol—GC—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.0231	0.0689	CbGpPWpGaD
Calcitriol—GC—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.0231	0.0689	CbGpPWpGaD
Calcitriol—CYP3A4—Etoposide—uterine cancer	0.0202	0.137	CbGbCtD
Calcitriol—CYP24A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.0171	0.0509	CbGpPWpGaD
Calcitriol—GC—renal system—uterine cancer	0.0141	0.111	CbGeAlD
Calcitriol—GC—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.0138	0.0412	CbGpPWpGaD
Calcitriol—CYP3A4—Doxorubicin—uterine cancer	0.0138	0.0935	CbGbCtD
Calcitriol—CYP24A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.0123	0.0368	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.0123	0.0368	CbGpPWpGaD
Calcitriol—CYP24A1—renal system—uterine cancer	0.0117	0.0927	CbGeAlD
Calcitriol—CYP24A1—endometrium—uterine cancer	0.0113	0.0897	CbGeAlD
Calcitriol—GC—female reproductive system—uterine cancer	0.0113	0.0892	CbGeAlD
Calcitriol—GC—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.0102	0.0303	CbGpPWpGaD
Calcitriol—CYP24A1—female reproductive system—uterine cancer	0.0094	0.0743	CbGeAlD
Calcitriol—CYP24A1—vagina—uterine cancer	0.0085	0.0672	CbGeAlD
Calcitriol—CYP24A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.00738	0.022	CbGpPWpGaD
Calcitriol—VDR—epithelium—uterine cancer	0.00697	0.0551	CbGeAlD
Calcitriol—VDR—uterine cervix—uterine cancer	0.00691	0.0546	CbGeAlD
Calcitriol—VDR—decidua—uterine cancer	0.00658	0.052	CbGeAlD
Calcitriol—VDR—renal system—uterine cancer	0.00646	0.0511	CbGeAlD
Calcitriol—VDR—Ovarian Infertility Genes—MLH1—uterine cancer	0.00615	0.0183	CbGpPWpGaD
Calcitriol—Cholecalciferol—CYP11A1—uterine cancer	0.00609	1	CrCbGaD
Calcitriol—VDR—mammalian vulva—uterine cancer	0.00605	0.0478	CbGeAlD
Calcitriol—VDR—Ovarian Infertility Genes—PGR—uterine cancer	0.00583	0.0174	CbGpPWpGaD
Calcitriol—VDR—uterus—uterine cancer	0.00576	0.0455	CbGeAlD
Calcitriol—CYP24A1—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.00543	0.0162	CbGpPWpGaD
Calcitriol—VDR—female reproductive system—uterine cancer	0.00518	0.0409	CbGeAlD
Calcitriol—VDR—Ovarian Infertility Genes—ESR2—uterine cancer	0.00514	0.0153	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—PGR—uterine cancer	0.00509	0.0152	CbGpPWpGaD
Calcitriol—VDR—female gonad—uterine cancer	0.00471	0.0372	CbGeAlD
Calcitriol—VDR—vagina—uterine cancer	0.00468	0.037	CbGeAlD
Calcitriol—VDR—Ovarian Infertility Genes—CYP19A1—uterine cancer	0.00466	0.0139	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00458	0.0136	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00452	0.0135	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—ESR2—uterine cancer	0.00448	0.0133	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00402	0.012	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—uterine cancer	0.00392	0.0117	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—SMAD3—uterine cancer	0.00382	0.0114	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00371	0.0111	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.00354	0.0105	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.00349	0.0104	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00337	0.01	CbGpPWpGaD
Calcitriol—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00332	0.00991	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00332	0.0099	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00328	0.00977	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.00325	0.00968	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—PMS2—uterine cancer	0.00312	0.0093	CbGpPWpGaD
Calcitriol—VDR—lymph node—uterine cancer	0.00303	0.0239	CbGeAlD
Calcitriol—Nasopharyngitis—Progesterone—uterine cancer	0.00276	0.00719	CcSEcCtD
Calcitriol—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00711	CcSEcCtD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00273	0.00814	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—ESR1—uterine cancer	0.00272	0.0081	CbGpPWpGaD
Calcitriol—Laboratory test abnormal—Doxorubicin—uterine cancer	0.0027	0.00703	CcSEcCtD
Calcitriol—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.00682	CcSEcCtD
Calcitriol—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.00256	0.00763	CbGpPWpGaD
Calcitriol—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00651	CcSEcCtD
Calcitriol—Pain—Carboplatin—uterine cancer	0.00247	0.00643	CcSEcCtD
Calcitriol—Weight decreased—Progesterone—uterine cancer	0.00242	0.00629	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.00238	0.00711	CbGpPWpGaD
Calcitriol—Drowsiness—Progesterone—uterine cancer	0.00238	0.00619	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00237	0.00706	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00237	0.00706	CbGpPWpGaD
Calcitriol—Conjunctivitis—Progesterone—uterine cancer	0.00231	0.00602	CcSEcCtD
Calcitriol—Urinary tract infection—Progesterone—uterine cancer	0.00231	0.00602	CcSEcCtD
Calcitriol—Body temperature increased—Carboplatin—uterine cancer	0.00229	0.00595	CcSEcCtD
Calcitriol—Urine abnormality—Epirubicin—uterine cancer	0.0022	0.00574	CcSEcCtD
Calcitriol—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.0057	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Etoposide—uterine cancer	0.00218	0.00566	CcSEcCtD
Calcitriol—CYP3A4—renal system—uterine cancer	0.00216	0.0171	CbGeAlD
Calcitriol—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00561	CcSEcCtD
Calcitriol—Haemoglobin—Progesterone—uterine cancer	0.00215	0.00559	CcSEcCtD
Calcitriol—VDR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00215	0.0064	CbGpPWpGaD
Calcitriol—Haemorrhage—Progesterone—uterine cancer	0.00214	0.00556	CcSEcCtD
Calcitriol—VDR—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.00212	0.00631	CbGpPWpGaD
Calcitriol—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00546	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MSH2—uterine cancer	0.0021	0.00625	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—GPX3—uterine cancer	0.00209	0.00624	CbGpPWpGaD
Calcitriol—Urine analysis abnormal—Epirubicin—uterine cancer	0.00208	0.0054	CcSEcCtD
Calcitriol—Urine abnormality—Doxorubicin—uterine cancer	0.00204	0.00531	CcSEcCtD
Calcitriol—Erythema multiforme—Progesterone—uterine cancer	0.00202	0.00526	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	0.00199	0.00593	CbGpPWpGaD
Calcitriol—Serum creatinine increased—Epirubicin—uterine cancer	0.00198	0.00516	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP11A1—uterine cancer	0.00197	0.00587	CbGpPWpGaD
Calcitriol—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00197	0.00512	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00196	0.00584	CbGpPWpGaD
Calcitriol—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00195	0.00506	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.00194	0.00579	CbGpPWpGaD
Calcitriol—Psoriasis—Epirubicin—uterine cancer	0.00194	0.00505	CcSEcCtD
Calcitriol—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00504	CcSEcCtD
Calcitriol—Urine analysis abnormal—Doxorubicin—uterine cancer	0.00192	0.005	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MLH1—uterine cancer	0.00189	0.00563	CbGpPWpGaD
Calcitriol—Erythema—Progesterone—uterine cancer	0.00186	0.00484	CcSEcCtD
Calcitriol—Serum creatinine increased—Doxorubicin—uterine cancer	0.00184	0.00478	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.00184	0.00547	CbGpPWpGaD
Calcitriol—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00476	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.00182	0.00473	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	0.00182	0.00541	CbGpPWpGaD
Calcitriol—Redness—Epirubicin—uterine cancer	0.00181	0.0047	CcSEcCtD
Calcitriol—Psoriasis—Doxorubicin—uterine cancer	0.0018	0.00467	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—uterine cancer	0.00176	0.00524	CbGpPWpGaD
Calcitriol—Hypercalcaemia—Epirubicin—uterine cancer	0.00176	0.00457	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00175	0.00521	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00174	0.00518	CbGpPWpGaD
Calcitriol—CYP3A4—female reproductive system—uterine cancer	0.00173	0.0137	CbGeAlD
Calcitriol—Blister—Epirubicin—uterine cancer	0.00169	0.00441	CcSEcCtD
Calcitriol—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00439	CcSEcCtD
Calcitriol—Redness—Doxorubicin—uterine cancer	0.00167	0.00435	CcSEcCtD
Calcitriol—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.0043	CcSEcCtD
Calcitriol—Albuminuria—Epirubicin—uterine cancer	0.00163	0.00425	CcSEcCtD
Calcitriol—Hypercalcaemia—Doxorubicin—uterine cancer	0.00163	0.00423	CcSEcCtD
Calcitriol—Convulsion—Progesterone—uterine cancer	0.00161	0.00419	CcSEcCtD
Calcitriol—Hypertension—Progesterone—uterine cancer	0.00161	0.00418	CcSEcCtD
Calcitriol—Chest pain—Progesterone—uterine cancer	0.00158	0.00412	CcSEcCtD
Calcitriol—Myalgia—Progesterone—uterine cancer	0.00158	0.00412	CcSEcCtD
Calcitriol—Anxiety—Progesterone—uterine cancer	0.00158	0.00411	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—uterine cancer	0.00157	0.00469	CbGpPWpGaD
Calcitriol—Blister—Doxorubicin—uterine cancer	0.00157	0.00408	CcSEcCtD
Calcitriol—Discomfort—Progesterone—uterine cancer	0.00157	0.00407	CcSEcCtD
Calcitriol—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00403	CcSEcCtD
Calcitriol—Dry mouth—Progesterone—uterine cancer	0.00155	0.00403	CcSEcCtD
Calcitriol—Anaphylactic shock—Progesterone—uterine cancer	0.00152	0.00395	CcSEcCtD
Calcitriol—Albuminuria—Doxorubicin—uterine cancer	0.00151	0.00394	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	0.00148	0.00442	CbGpPWpGaD
Calcitriol—Skin disorder—Progesterone—uterine cancer	0.00148	0.00384	CcSEcCtD
Calcitriol—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.0038	CcSEcCtD
Calcitriol—GC—Metabolism—NDUFB11—uterine cancer	0.00146	0.00435	CbGpPWpGaD
Calcitriol—GC—Metabolism—SRD5A2—uterine cancer	0.00146	0.00435	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—CYP19A1—uterine cancer	0.00145	0.00432	CbGpPWpGaD
Calcitriol—Anorexia—Progesterone—uterine cancer	0.00145	0.00377	CcSEcCtD
Calcitriol—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00373	CcSEcCtD
Calcitriol—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00373	CcSEcCtD
Calcitriol—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00372	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP19A1—uterine cancer	0.00143	0.00426	CbGpPWpGaD
Calcitriol—Neoplasm malignant—Epirubicin—uterine cancer	0.00143	0.00372	CcSEcCtD
Calcitriol—Erythema multiforme—Dactinomycin—uterine cancer	0.00143	0.00372	CcSEcCtD
Calcitriol—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00369	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00142	0.00422	CbGpPWpGaD
Calcitriol—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00365	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00138	0.0036	CcSEcCtD
Calcitriol—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00358	CcSEcCtD
Calcitriol—Insomnia—Progesterone—uterine cancer	0.00137	0.00357	CcSEcCtD
Calcitriol—Somnolence—Progesterone—uterine cancer	0.00135	0.00351	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00134	0.00399	CbGpPWpGaD
Calcitriol—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00348	CcSEcCtD
Calcitriol—Neoplasm malignant—Doxorubicin—uterine cancer	0.00132	0.00344	CcSEcCtD
Calcitriol—Decreased appetite—Progesterone—uterine cancer	0.00132	0.00343	CcSEcCtD
Calcitriol—Nocturia—Epirubicin—uterine cancer	0.00132	0.00342	CcSEcCtD
Calcitriol—Erythema—Dactinomycin—uterine cancer	0.00132	0.00342	CcSEcCtD
Calcitriol—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00341	CcSEcCtD
Calcitriol—Pain—Progesterone—uterine cancer	0.0013	0.00338	CcSEcCtD
Calcitriol—Constipation—Progesterone—uterine cancer	0.0013	0.00338	CcSEcCtD
Calcitriol—Bone pain—Epirubicin—uterine cancer	0.00127	0.00331	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00126	0.00377	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00126	0.00377	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00326	CcSEcCtD
Calcitriol—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00324	CcSEcCtD
Calcitriol—Gastrointestinal pain—Progesterone—uterine cancer	0.00124	0.00323	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—EP300—uterine cancer	0.00122	0.00365	CbGpPWpGaD
Calcitriol—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00318	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.00122	0.00318	CcSEcCtD
Calcitriol—Nocturia—Doxorubicin—uterine cancer	0.00122	0.00317	CcSEcCtD
Calcitriol—Urticaria—Progesterone—uterine cancer	0.00121	0.00314	CcSEcCtD
Calcitriol—Abdominal pain—Progesterone—uterine cancer	0.0012	0.00312	CcSEcCtD
Calcitriol—Body temperature increased—Progesterone—uterine cancer	0.0012	0.00312	CcSEcCtD
Calcitriol—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00311	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00118	0.00353	CbGpPWpGaD
Calcitriol—Bone pain—Doxorubicin—uterine cancer	0.00118	0.00307	CcSEcCtD
Calcitriol—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00306	CcSEcCtD
Calcitriol—Blood urea increased—Epirubicin—uterine cancer	0.00115	0.003	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.00113	0.00294	CcSEcCtD
Calcitriol—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00293	CcSEcCtD
Calcitriol—Myalgia—Dactinomycin—uterine cancer	0.00112	0.00291	CcSEcCtD
Calcitriol—Hypersensitivity—Progesterone—uterine cancer	0.00112	0.00291	CcSEcCtD
Calcitriol—Discomfort—Dactinomycin—uterine cancer	0.00111	0.00288	CcSEcCtD
Calcitriol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00284	CcSEcCtD
Calcitriol—Asthenia—Progesterone—uterine cancer	0.00109	0.00283	CcSEcCtD
Calcitriol—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00283	CcSEcCtD
Calcitriol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00283	CcSEcCtD
Calcitriol—Pruritus—Progesterone—uterine cancer	0.00107	0.0028	CcSEcCtD
Calcitriol—Blood urea increased—Doxorubicin—uterine cancer	0.00107	0.00277	CcSEcCtD
Calcitriol—GC—Metabolism—AKR1B1—uterine cancer	0.00105	0.00314	CbGpPWpGaD
Calcitriol—GC—Metabolism—STAR—uterine cancer	0.00105	0.00314	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00104	0.00311	CbGpPWpGaD
Calcitriol—Diarrhoea—Progesterone—uterine cancer	0.00104	0.0027	CcSEcCtD
Calcitriol—Erythema multiforme—Etoposide—uterine cancer	0.00103	0.00269	CcSEcCtD
Calcitriol—Anorexia—Dactinomycin—uterine cancer	0.00102	0.00266	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.00102	0.00265	CcSEcCtD
Calcitriol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00264	CcSEcCtD
Calcitriol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00257	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000978	0.00254	CcSEcCtD
Calcitriol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000974	0.00253	CcSEcCtD
Calcitriol—Vomiting—Progesterone—uterine cancer	0.000966	0.00251	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MET—uterine cancer	0.000961	0.00286	CbGpPWpGaD
Calcitriol—Rash—Progesterone—uterine cancer	0.000957	0.00249	CcSEcCtD
Calcitriol—Dermatitis—Progesterone—uterine cancer	0.000957	0.00249	CcSEcCtD
Calcitriol—Headache—Progesterone—uterine cancer	0.000951	0.00247	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000942	0.00245	CcSEcCtD
Calcitriol—VDR—Gene Expression—PHF1—uterine cancer	0.000942	0.00281	CbGpPWpGaD
Calcitriol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000942	0.00245	CcSEcCtD
Calcitriol—Decreased appetite—Dactinomycin—uterine cancer	0.000933	0.00243	CcSEcCtD
Calcitriol—Dysgeusia—Etoposide—uterine cancer	0.000932	0.00242	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000928	0.00277	CbGpPWpGaD
Calcitriol—Dermatitis bullous—Epirubicin—uterine cancer	0.000927	0.00241	CcSEcCtD
Calcitriol—Pain—Dactinomycin—uterine cancer	0.000918	0.00239	CcSEcCtD
Calcitriol—Nausea—Progesterone—uterine cancer	0.000902	0.00235	CcSEcCtD
Calcitriol—Pain in extremity—Epirubicin—uterine cancer	0.000886	0.0023	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	0.000885	0.00264	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000878	0.00228	CcSEcCtD
Calcitriol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000875	0.00228	CcSEcCtD
Calcitriol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000868	0.00226	CcSEcCtD
Calcitriol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000867	0.00226	CcSEcCtD
Calcitriol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00224	CcSEcCtD
Calcitriol—Dermatitis bullous—Doxorubicin—uterine cancer	0.000858	0.00223	CcSEcCtD
Calcitriol—Body temperature increased—Dactinomycin—uterine cancer	0.000848	0.00221	CcSEcCtD
Calcitriol—Abdominal pain—Dactinomycin—uterine cancer	0.000848	0.00221	CcSEcCtD
Calcitriol—Blood creatinine increased—Epirubicin—uterine cancer	0.00083	0.00216	CcSEcCtD
Calcitriol—GC—Metabolism—POLD1—uterine cancer	0.000828	0.00247	CbGpPWpGaD
Calcitriol—Convulsion—Etoposide—uterine cancer	0.000825	0.00215	CcSEcCtD
Calcitriol—Dehydration—Epirubicin—uterine cancer	0.000824	0.00214	CcSEcCtD
Calcitriol—Hypertension—Etoposide—uterine cancer	0.000822	0.00214	CcSEcCtD
Calcitriol—Pain in extremity—Doxorubicin—uterine cancer	0.00082	0.00213	CcSEcCtD
Calcitriol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.00213	CcSEcCtD
Calcitriol—Chest pain—Etoposide—uterine cancer	0.00081	0.00211	CcSEcCtD
Calcitriol—Abdominal pain upper—Epirubicin—uterine cancer	0.000809	0.00211	CcSEcCtD
Calcitriol—VDR—Gene Expression—CHD4—uterine cancer	0.000801	0.00239	CbGpPWpGaD
Calcitriol—Discomfort—Etoposide—uterine cancer	0.000801	0.00208	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000798	0.00208	CcSEcCtD
Calcitriol—Nasopharyngitis—Epirubicin—uterine cancer	0.000792	0.00206	CcSEcCtD
Calcitriol—Hypersensitivity—Dactinomycin—uterine cancer	0.000791	0.00206	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—SRD5A2—uterine cancer	0.000779	0.00232	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—NDUFB11—uterine cancer	0.000779	0.00232	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Etoposide—uterine cancer	0.000777	0.00202	CcSEcCtD
Calcitriol—GC—Metabolism—AKR1C1—uterine cancer	0.000774	0.00231	CbGpPWpGaD
Calcitriol—Asthenia—Dactinomycin—uterine cancer	0.00077	0.002	CcSEcCtD
Calcitriol—Blood creatinine increased—Doxorubicin—uterine cancer	0.000768	0.002	CcSEcCtD
Calcitriol—Dehydration—Doxorubicin—uterine cancer	0.000762	0.00198	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000757	0.00226	CbGpPWpGaD
Calcitriol—Skin disorder—Etoposide—uterine cancer	0.000755	0.00196	CcSEcCtD
Calcitriol—Pancreatitis—Epirubicin—uterine cancer	0.000751	0.00195	CcSEcCtD
Calcitriol—Abdominal pain upper—Doxorubicin—uterine cancer	0.000749	0.00195	CcSEcCtD
Calcitriol—Anorexia—Etoposide—uterine cancer	0.00074	0.00193	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000738	0.00192	CcSEcCtD
Calcitriol—Diarrhoea—Dactinomycin—uterine cancer	0.000734	0.00191	CcSEcCtD
Calcitriol—Nasopharyngitis—Doxorubicin—uterine cancer	0.000733	0.00191	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000715	0.00213	CbGpPWpGaD
Calcitriol—Pancreatitis—Doxorubicin—uterine cancer	0.000695	0.00181	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—PGR—uterine cancer	0.000694	0.00207	CbGpPWpGaD
Calcitriol—Weight decreased—Epirubicin—uterine cancer	0.000693	0.0018	CcSEcCtD
Calcitriol—Somnolence—Etoposide—uterine cancer	0.000691	0.0018	CcSEcCtD
Calcitriol—GC—Metabolism—RRM2—uterine cancer	0.00069	0.00206	CbGpPWpGaD
Calcitriol—Drowsiness—Epirubicin—uterine cancer	0.000683	0.00178	CcSEcCtD
Calcitriol—Vomiting—Dactinomycin—uterine cancer	0.000682	0.00178	CcSEcCtD
Calcitriol—Rash—Dactinomycin—uterine cancer	0.000677	0.00176	CcSEcCtD
Calcitriol—Decreased appetite—Etoposide—uterine cancer	0.000675	0.00176	CcSEcCtD
Calcitriol—VDR—Gene Expression—SUZ12—uterine cancer	0.000671	0.002	CbGpPWpGaD
Calcitriol—GC—Metabolism—DCN—uterine cancer	0.00067	0.002	CbGpPWpGaD
Calcitriol—Pain—Etoposide—uterine cancer	0.000664	0.00173	CcSEcCtD
Calcitriol—Constipation—Etoposide—uterine cancer	0.000664	0.00173	CcSEcCtD
Calcitriol—Urinary tract infection—Epirubicin—uterine cancer	0.000664	0.00173	CcSEcCtD
Calcitriol—Conjunctivitis—Epirubicin—uterine cancer	0.000664	0.00173	CcSEcCtD
Calcitriol—Weight decreased—Doxorubicin—uterine cancer	0.000641	0.00167	CcSEcCtD
Calcitriol—Nausea—Dactinomycin—uterine cancer	0.000638	0.00166	CcSEcCtD
Calcitriol—Gastrointestinal pain—Etoposide—uterine cancer	0.000635	0.00165	CcSEcCtD
Calcitriol—Drowsiness—Doxorubicin—uterine cancer	0.000632	0.00164	CcSEcCtD
Calcitriol—GC—Metabolism—CYP11A1—uterine cancer	0.000631	0.00188	CbGpPWpGaD
Calcitriol—Urticaria—Etoposide—uterine cancer	0.000617	0.00161	CcSEcCtD
Calcitriol—Haemoglobin—Epirubicin—uterine cancer	0.000616	0.0016	CcSEcCtD
Calcitriol—Abdominal pain—Etoposide—uterine cancer	0.000614	0.0016	CcSEcCtD
Calcitriol—Body temperature increased—Etoposide—uterine cancer	0.000614	0.0016	CcSEcCtD
Calcitriol—Urinary tract infection—Doxorubicin—uterine cancer	0.000614	0.0016	CcSEcCtD
Calcitriol—Conjunctivitis—Doxorubicin—uterine cancer	0.000614	0.0016	CcSEcCtD
Calcitriol—Haemorrhage—Epirubicin—uterine cancer	0.000613	0.00159	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—ESR2—uterine cancer	0.000611	0.00182	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—PTEN—uterine cancer	0.000599	0.00179	CbGpPWpGaD
Calcitriol—GC—Metabolism—AKR1C3—uterine cancer	0.000596	0.00178	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000594	0.00177	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000586	0.00175	CbGpPWpGaD
Calcitriol—Erythema multiforme—Epirubicin—uterine cancer	0.00058	0.00151	CcSEcCtD
Calcitriol—Hypersensitivity—Etoposide—uterine cancer	0.000572	0.00149	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—EP300—uterine cancer	0.000571	0.0017	CbGpPWpGaD
Calcitriol—Haemoglobin—Doxorubicin—uterine cancer	0.00057	0.00148	CcSEcCtD
Calcitriol—Haemorrhage—Doxorubicin—uterine cancer	0.000567	0.00148	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—STAR—uterine cancer	0.000563	0.00168	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—AKR1B1—uterine cancer	0.000563	0.00168	CbGpPWpGaD
Calcitriol—Asthenia—Etoposide—uterine cancer	0.000557	0.00145	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000557	0.00166	CbGpPWpGaD
Calcitriol—Pruritus—Etoposide—uterine cancer	0.00055	0.00143	CcSEcCtD
Calcitriol—Arrhythmia—Epirubicin—uterine cancer	0.000548	0.00142	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.00054	0.00161	CbGpPWpGaD
Calcitriol—Erythema multiforme—Doxorubicin—uterine cancer	0.000536	0.0014	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	0.000535	0.00159	CbGpPWpGaD
Calcitriol—Erythema—Epirubicin—uterine cancer	0.000534	0.00139	CcSEcCtD
Calcitriol—Diarrhoea—Etoposide—uterine cancer	0.000532	0.00138	CcSEcCtD
Calcitriol—Dysgeusia—Epirubicin—uterine cancer	0.000522	0.00136	CcSEcCtD
Calcitriol—Arrhythmia—Doxorubicin—uterine cancer	0.000507	0.00132	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000497	0.00148	CbGpPWpGaD
Calcitriol—Vomiting—Etoposide—uterine cancer	0.000494	0.00128	CcSEcCtD
Calcitriol—Erythema—Doxorubicin—uterine cancer	0.000494	0.00128	CcSEcCtD
Calcitriol—Agitation—Epirubicin—uterine cancer	0.00049	0.00128	CcSEcCtD
Calcitriol—Rash—Etoposide—uterine cancer	0.00049	0.00127	CcSEcCtD
Calcitriol—Dermatitis—Etoposide—uterine cancer	0.000489	0.00127	CcSEcCtD
Calcitriol—Headache—Etoposide—uterine cancer	0.000487	0.00127	CcSEcCtD
Calcitriol—Dysgeusia—Doxorubicin—uterine cancer	0.000483	0.00126	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000481	0.00144	CbGpPWpGaD
Calcitriol—GC—Metabolism—STK11—uterine cancer	0.000464	0.00138	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP19A1—uterine cancer	0.000464	0.00138	CbGpPWpGaD
Calcitriol—Convulsion—Epirubicin—uterine cancer	0.000462	0.0012	CcSEcCtD
Calcitriol—Nausea—Etoposide—uterine cancer	0.000461	0.0012	CcSEcCtD
Calcitriol—Hypertension—Epirubicin—uterine cancer	0.000461	0.0012	CcSEcCtD
Calcitriol—Myalgia—Epirubicin—uterine cancer	0.000454	0.00118	CcSEcCtD
Calcitriol—Chest pain—Epirubicin—uterine cancer	0.000454	0.00118	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—SMAD3—uterine cancer	0.000454	0.00135	CbGpPWpGaD
Calcitriol—Agitation—Doxorubicin—uterine cancer	0.000454	0.00118	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000453	0.00135	CbGpPWpGaD
Calcitriol—Anxiety—Epirubicin—uterine cancer	0.000453	0.00118	CcSEcCtD
Calcitriol—Discomfort—Epirubicin—uterine cancer	0.000449	0.00117	CcSEcCtD
Calcitriol—Dry mouth—Epirubicin—uterine cancer	0.000444	0.00116	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—POLD1—uterine cancer	0.000442	0.00132	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000437	0.0013	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000436	0.0013	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Epirubicin—uterine cancer	0.000435	0.00113	CcSEcCtD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000431	0.00129	CbGpPWpGaD
Calcitriol—Convulsion—Doxorubicin—uterine cancer	0.000428	0.00111	CcSEcCtD
Calcitriol—Hypertension—Doxorubicin—uterine cancer	0.000426	0.00111	CcSEcCtD
Calcitriol—Skin disorder—Epirubicin—uterine cancer	0.000423	0.0011	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000421	0.00126	CbGpPWpGaD
Calcitriol—Myalgia—Doxorubicin—uterine cancer	0.00042	0.00109	CcSEcCtD
Calcitriol—Chest pain—Doxorubicin—uterine cancer	0.00042	0.00109	CcSEcCtD
Calcitriol—Anxiety—Doxorubicin—uterine cancer	0.000419	0.00109	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000416	0.00124	CbGpPWpGaD
Calcitriol—Discomfort—Doxorubicin—uterine cancer	0.000415	0.00108	CcSEcCtD
Calcitriol—Anorexia—Epirubicin—uterine cancer	0.000415	0.00108	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—AKR1C1—uterine cancer	0.000413	0.00123	CbGpPWpGaD
Calcitriol—Dry mouth—Doxorubicin—uterine cancer	0.000411	0.00107	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—TP53—uterine cancer	0.000409	0.00122	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Doxorubicin—uterine cancer	0.000403	0.00105	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000397	0.00103	CcSEcCtD
Calcitriol—Insomnia—Epirubicin—uterine cancer	0.000394	0.00102	CcSEcCtD
Calcitriol—Skin disorder—Doxorubicin—uterine cancer	0.000391	0.00102	CcSEcCtD
Calcitriol—Somnolence—Epirubicin—uterine cancer	0.000387	0.00101	CcSEcCtD
Calcitriol—Anorexia—Doxorubicin—uterine cancer	0.000384	0.000999	CcSEcCtD
Calcitriol—Decreased appetite—Epirubicin—uterine cancer	0.000379	0.000985	CcSEcCtD
Calcitriol—Pain—Epirubicin—uterine cancer	0.000372	0.000969	CcSEcCtD
Calcitriol—Constipation—Epirubicin—uterine cancer	0.000372	0.000969	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—ESR1—uterine cancer	0.000371	0.0011	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—RRM2—uterine cancer	0.000368	0.0011	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000367	0.000955	CcSEcCtD
Calcitriol—Insomnia—Doxorubicin—uterine cancer	0.000364	0.000948	CcSEcCtD
Calcitriol—Somnolence—Doxorubicin—uterine cancer	0.000358	0.000932	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—DCN—uterine cancer	0.000358	0.00107	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Epirubicin—uterine cancer	0.000356	0.000926	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000354	0.00106	CbGpPWpGaD
Calcitriol—Decreased appetite—Doxorubicin—uterine cancer	0.00035	0.000911	CcSEcCtD
Calcitriol—GC—Metabolism—MTHFR—uterine cancer	0.000349	0.00104	CbGpPWpGaD
Calcitriol—Urticaria—Epirubicin—uterine cancer	0.000346	0.0009	CcSEcCtD
Calcitriol—Constipation—Doxorubicin—uterine cancer	0.000345	0.000896	CcSEcCtD
Calcitriol—Pain—Doxorubicin—uterine cancer	0.000345	0.000896	CcSEcCtD
Calcitriol—Body temperature increased—Epirubicin—uterine cancer	0.000344	0.000896	CcSEcCtD
Calcitriol—Abdominal pain—Epirubicin—uterine cancer	0.000344	0.000896	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—CYP11A1—uterine cancer	0.000337	0.001	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PGR—uterine cancer	0.000334	0.000996	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000329	0.000857	CcSEcCtD
Calcitriol—Hypersensitivity—Epirubicin—uterine cancer	0.000321	0.000835	CcSEcCtD
Calcitriol—Urticaria—Doxorubicin—uterine cancer	0.00032	0.000833	CcSEcCtD
Calcitriol—Abdominal pain—Doxorubicin—uterine cancer	0.000319	0.000829	CcSEcCtD
Calcitriol—Body temperature increased—Doxorubicin—uterine cancer	0.000319	0.000829	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—AKR1C3—uterine cancer	0.000318	0.000949	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—EZH2—uterine cancer	0.000317	0.000946	CbGpPWpGaD
Calcitriol—Asthenia—Epirubicin—uterine cancer	0.000312	0.000813	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000309	0.000922	CbGpPWpGaD
Calcitriol—Pruritus—Epirubicin—uterine cancer	0.000308	0.000801	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000307	0.000917	CbGpPWpGaD
Calcitriol—Diarrhoea—Epirubicin—uterine cancer	0.000298	0.000775	CcSEcCtD
Calcitriol—Hypersensitivity—Doxorubicin—uterine cancer	0.000297	0.000772	CcSEcCtD
Calcitriol—VDR—Gene Expression—ESR2—uterine cancer	0.000294	0.000877	CbGpPWpGaD
Calcitriol—Asthenia—Doxorubicin—uterine cancer	0.000289	0.000752	CcSEcCtD
Calcitriol—Pruritus—Doxorubicin—uterine cancer	0.000285	0.000742	CcSEcCtD
Calcitriol—Vomiting—Epirubicin—uterine cancer	0.000277	0.00072	CcSEcCtD
Calcitriol—Diarrhoea—Doxorubicin—uterine cancer	0.000276	0.000717	CcSEcCtD
Calcitriol—Rash—Epirubicin—uterine cancer	0.000275	0.000714	CcSEcCtD
Calcitriol—Dermatitis—Epirubicin—uterine cancer	0.000274	0.000714	CcSEcCtD
Calcitriol—Headache—Epirubicin—uterine cancer	0.000273	0.00071	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000272	0.00081	CbGpPWpGaD
Calcitriol—Nausea—Epirubicin—uterine cancer	0.000259	0.000673	CcSEcCtD
Calcitriol—Vomiting—Doxorubicin—uterine cancer	0.000256	0.000666	CcSEcCtD
Calcitriol—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000256	0.000762	CbGpPWpGaD
Calcitriol—Rash—Doxorubicin—uterine cancer	0.000254	0.000661	CcSEcCtD
Calcitriol—Dermatitis—Doxorubicin—uterine cancer	0.000254	0.00066	CcSEcCtD
Calcitriol—Headache—Doxorubicin—uterine cancer	0.000252	0.000657	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000252	0.000752	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—STK11—uterine cancer	0.000248	0.000739	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP19A1—uterine cancer	0.000248	0.000739	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—CDKN2B—uterine cancer	0.00024	0.000714	CbGpPWpGaD
Calcitriol—Nausea—Doxorubicin—uterine cancer	0.000239	0.000623	CcSEcCtD
Calcitriol—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000238	0.00071	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000233	0.000694	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000222	0.000662	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SMAD3—uterine cancer	0.000219	0.000652	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTEN—uterine cancer	0.000194	0.000579	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	0.000188	0.000561	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—MTHFR—uterine cancer	0.000186	0.000555	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	0.000186	0.000553	CbGpPWpGaD
Calcitriol—GC—Metabolism—EP300—uterine cancer	0.000185	0.000552	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—ESR1—uterine cancer	0.000178	0.000532	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000164	0.000489	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CA—uterine cancer	0.000137	0.000408	CbGpPWpGaD
Calcitriol—GC—Metabolism—AKT1—uterine cancer	0.000112	0.000333	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTEN—uterine cancer	0.000104	0.000309	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NDUFB11—uterine cancer	0.000101	0.000301	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SRD5A2—uterine cancer	0.000101	0.000301	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—EP300—uterine cancer	9.88e-05	0.000295	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CA—uterine cancer	7.31e-05	0.000218	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—STAR—uterine cancer	7.31e-05	0.000218	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.31e-05	0.000218	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—AKT1—uterine cancer	6.44e-05	0.000192	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—AKT1—uterine cancer	5.97e-05	0.000178	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—POLD1—uterine cancer	5.73e-05	0.000171	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.36e-05	0.00016	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—RRM2—uterine cancer	4.78e-05	0.000143	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—DCN—uterine cancer	4.64e-05	0.000138	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.37e-05	0.00013	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.13e-05	0.000123	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—STK11—uterine cancer	3.22e-05	9.59e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.22e-05	9.59e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—MTHFR—uterine cancer	2.42e-05	7.21e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTEN—uterine cancer	1.34e-05	4.01e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—EP300—uterine cancer	1.28e-05	3.82e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CA—uterine cancer	9.49e-06	2.83e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKT1—uterine cancer	7.75e-06	2.31e-05	CbGpPWpGaD
